CPHI [CHINA PHARMA] DEFA14A:
[]
BSPM [Biostar Pharmaceuticals] DEF 14A: (Original Filing)
[Schedule 14A x o Check the appropriate box: o o x o o Biostar Pharmaceuticals, Inc. _____________________________________ Payment of Filing Fee (Check the appropriate box): x o (1) Title of each class of securities to which transaction applies: _____________________________ (2) Aggregate number of securities to which transaction applies: ____________________________ (3) (4) Proposed maximum aggregate value of transaction: ______________________________________ (5) Total]
BSPM [Biostar Pharmaceuticals] DEF 14A: Schedule 14A x o Check the appropriate box:
[Schedule 14A x o Check the appropriate box: o o x o o Biostar Pharmaceuticals, Inc. _____________________________________ Payment of Filing Fee (Check the appropriate box): x o (1) Title of each class of securities to which transaction applies: _____________________________ (2) Aggregate number of securities to which transaction applies: ____________________________ (3) (4) Proposed maximum aggregate value of transaction: ______________________________________ (5) Total]
SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)
[SKYSTAR BIO-PHARMACEUTICAL COMPANY ANNOUNCES RECEIPT OF NASDAQ NOTIFICATION LETTER Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, announced today that on October 20, 2015 it received a letter from NASDAQ Stock Market indicating that that Skystar failed to comply with Nasdaq’s filing requirement set forth in Listing Rule 5250(c)(1) (the] []
WX [WuXi PharmaTech (Cayman)] 6-K: (Original Filing)
[Form 6-K TABLE OF CONTENTS 3 4 2 WuXi PharmaTech (Cayman) Inc. Edward Hu Chief Financial Officer 3]
WX [WuXi PharmaTech (Cayman)] 6-K: Form 6-K TABLE OF CONTENTS 3 4 2
[Form 6-K TABLE OF CONTENTS 3 4 2 WuXi PharmaTech (Cayman) Inc. Edward Hu Chief Financial Officer 3]
WX [WuXi PharmaTech (Cayman)] SC 13E3/A: (Original Filing)
[PROXY STATEMENT OF THE COMPANY October 20, 2015 Shareholders of WuXi PharmaTech (Cayman) Inc. Re: Notice of Extraordinary General Meeting of Shareholders Dear Shareholder: You are cordially invited to attend an extraordinary general meeting of shareholders of WuXi PharmaTech (Cayman) Inc., an exempted company with limited liability incorporated under the laws of the Cayman Islands (the Company), to be held] [EXECUTION VERSION SECOND AMENDED AND RESTATED CONSORTIUM AGREEMENT THIS SECOND AMENDED AND RESTATED CONSORTIUM AGREEMENT Agreement Chairman ABG Boyu Initial Sponsors G&C Temasek Hillhouse PRC Ping An G&C IV Co-Founder Equity LP Yunfeng Sequoia Legend Capital SPDBI Principal Consortium Member Principal Consortium Members Party Sponsor Parties Sponsors WHEREAS Original Consortium Agreement Transaction Company NYSE Exchange Act WHEREAS A&R Consortium Agreement] [EXECUTION VERSION CONFIDENTIAL AMENDED AND RESTATED INTERIM INVESTORS AGREEMENT Agreement Chairman Management Roll-over Entity ABG Boyu Temasek Hillhouse Ping An G&C IV Co-Founder Equity LP Yunfeng Sequoia Legend Capital SPDBI Equity Sponsor Equity Sponsors Investor Investors Holdco Parent Merger Sub Parties Party This Amended and Restated Interim Investors Agreement (this RECITALS Original Interim Investors Agreement WHEREAS, on August 14,] []
WX [WuXi PharmaTech (Cayman)] SC 13E3/A: PROXY STATEMENT OF THE COMPANY October 20, 2015
[PROXY STATEMENT OF THE COMPANY October 20, 2015 Shareholders of WuXi PharmaTech (Cayman) Inc. Re: Notice of Extraordinary General Meeting of Shareholders Dear Shareholder: You are cordially invited to attend an extraordinary general meeting of shareholders of WuXi PharmaTech (Cayman) Inc., an exempted company with limited liability incorporated under the laws of the Cayman Islands (the Company), to be held] [EXECUTION VERSION SECOND AMENDED AND RESTATED CONSORTIUM AGREEMENT THIS SECOND AMENDED AND RESTATED CONSORTIUM AGREEMENT Agreement Chairman ABG Boyu Initial Sponsors G&C Temasek Hillhouse PRC Ping An G&C IV Co-Founder Equity LP Yunfeng Sequoia Legend Capital SPDBI Principal Consortium Member Principal Consortium Members Party Sponsor Parties Sponsors WHEREAS Original Consortium Agreement Transaction Company NYSE Exchange Act WHEREAS A&R Consortium Agreement] [EXECUTION VERSION CONFIDENTIAL AMENDED AND RESTATED INTERIM INVESTORS AGREEMENT Agreement Chairman Management Roll-over Entity ABG Boyu Temasek Hillhouse Ping An G&C IV Co-Founder Equity LP Yunfeng Sequoia Legend Capital SPDBI Equity Sponsor Equity Sponsors Investor Investors Holdco Parent Merger Sub Parties Party This Amended and Restated Interim Investors Agreement (this RECITALS Original Interim Investors Agreement WHEREAS, on August 14,] []
